Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI –ANRS136 Trial over 96 Weeks

BACKGROUND: A higher proportion of intermittent viremia (to have a HIV-1 RNA viral load>50 copies/mL not confirmed) was reported in the boosted protease inhibitor monotherapy arm in some studies including MONOI trial, and that could have an impact on the replenishment of the HIV-1 DNA reservoirs....

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert-Niclot, Sidonie, Flandre, Philippe, Valantin, Marc-Antoine, Soulie, Cathia, Fourati, Slim, Wirden, Marc, Sayon, Sophie, Pakianather, Sophie, Bocket, Laurence, Masquelier, Bernard, Dos Santos, Georges, Katlama, Christine, Calvez, Vincent, Marcelin, Anne-Genevieve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405120/
https://www.ncbi.nlm.nih.gov/pubmed/22848481
http://dx.doi.org/10.1371/journal.pone.0041390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405120/
https://www.ncbi.nlm.nih.gov/pubmed/22848481
http://dx.doi.org/10.1371/journal.pone.0041390

Ejemplares similares